Australia’s medical regulator has approved use of its first coronavirus vaccine, paving the way for inoculations to begin next month.
The Therapeutic Goods Administration on Monday gave provisional approval for people aged 16 and over to use the vaccine developed by Pfizer and BioNTech.
Residents and workers at aged-care facilities, frontline healthcare workers and quarantine workers are among the groups being prioritised for the first doses.
Australian Prime Minister Scott Morrison welcomed the development. He said Australia was among the first countries to complete a comprehensive process to formally approve a vaccine rather than just grant an emergency approval.
Highest dosing rate
Australia has an agreement for 10 million doses of the two-dose Pfizer vaccine and an option to buy more if supplies allow.
Health Minister Greg Hunt said Monday the country overall had secured 140 million vaccines, one of the highest dosing rates per head of population in the world.
The biggest of the pre-orders, conditional on regulatory approval, is 53.8 million doses of the vaccine made by AstraZeneca and Oxford University, 50 million of which would be made in Australia in a partnership with Melbourne-based biopharmaceutical company CSL.
Australia is aiming to complete inoculations by October. The nation of 26 million people has reported fewer than 30,000 virus cases and a little over 900 deaths.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.